ACACA and cancer: However, enhanced protein acetylation by ACC1 inhibition and acetyl-CoA accumulation leads to the activations of inflammation- and anti-apoptotic-related genes in prostate (PC3) and ovarian (OVCAR3) cancer cells [9], suggesting the outcomes of acetyl-CoA accumulation appear to be cell type-dependent.